Proteolysis of Plasmodium falciparum surface antigen, Pfs230, during gametogenesis.
During Plasmodium falciparum gametogenesis, proteolysis of Pfs230, a 360 kDa gametocyte surface protein, generates two large polypeptides, 307 and 300 kDa, that remain associated with the surface of the newly formed gamete. Using peptide specific antibodies, the amino termini of the 307 and 300 kDa forms have been mapped to between aa 477-487 and aa 523-555, respectively, which is the region between the glutamate rich repeats and the cysteine motif domains. Concomitantly, two peptides, 47 and 35 kDa, corresponding to the region upstream from the cleavage site are released into the medium. The membrane permeant cysteine protease inhibitor, E64d, blocks production of the 300 and 35 kDa forms of Pfs230, but does not alter the formation of the 307 or 47 kDa forms. In contrast, E64, which has been shown to inhibit the development of P. falciparum trophozoites, does not block proteolytic processing of Pfs230. Production of both the 307 and 300 kDa forms was reduced by a metallo-protease inhibitor, 1,10-phenanthroline, whereas the rest of the protease inhibitors tested had no effect on Pfs230 processing. This is the first study of proteolysis during gametogenesis and it demonstrates that the two large forms of Pfs230 produced are generated by proteases with different specificities. The data also suggest that Pfs230 undergoes proteolytic processing prior to emergence from the red blood cell.
Brooks
S R
SR
Department of Biology, Loyola University of Chicago, IL 60626, USA.
Williamson
K C
KC
D000818:Animals; D000953:Antigens, Protozoan / Q000032:analysis* / Q000235:genetics; D000954:Antigens, Surface / Q000032:analysis* / Q000235:genetics; D003546:Cysteine Endopeptidases / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D005718:Gametogenesis / Q000276:immunology*; D005854:Germ Cells / Q000276:immunology; D015151:Immunoblotting; D010436:Pepstatins / Q000494:pharmacology; D010618:Phenanthrolines / Q000494:pharmacology; D010664:Phenylmethylsulfonyl Fluoride / Q000494:pharmacology; D010963:Plasmodium falciparum / Q000276:immunology*; D011480:Protease Inhibitors / Q000494:pharmacology; D014977:Xanthurenates
D000953:Antigens, Protozoan; D000954:Antigens, Surface; D010436:Pepstatins; D010618:Phenanthrolines; D011480:Protease Inhibitors; D014977:Xanthurenates; C014195:Streptomyces pepsin inhibitor; D010664:Phenylmethylsulfonyl Fluoride; C028330:xanthurenic acid; D003546:Cysteine Endopeptidases; C031375:pepstatin; C025205:1,10-phenanthroline; D004121:Dimethyl Sulfoxide